These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10350138)

  • 1. Selective effects of antileukotrienes on leukotriene and histamine release in human dispersed lung cells.
    Larsson L; Sydbom A; Dahlén SE
    Inflamm Res; 1999 Apr; 48 Suppl 1():S9-10. PubMed ID: 10350138
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of asthma with antileukotrienes: first line or last resort therapy?
    Dahlén SE
    Eur J Pharmacol; 2006 Mar; 533(1-3):40-56. PubMed ID: 16510137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi.
    Ellis JL; Undem BJ
    Am J Respir Crit Care Med; 1994 Jan; 149(1):118-22. PubMed ID: 8111568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Inhibition of Histamine H1 Receptors and Leukotrienes Reduces Compound 48/80-Induced Contraction of the Human Bronchus in vitro.
    Benko R; Molnar TF; Szombati V; Benkö I; Bartho L
    Pharmacology; 2015; 96(5-6):253-5. PubMed ID: 26394300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
    Knapp HR
    N Engl J Med; 1990 Dec; 323(25):1745-8. PubMed ID: 1701029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
    Tennant CM; Seale JP; Temple DM
    J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice.
    Gunning WT; Kramer PM; Steele VE; Pereira MA
    Cancer Res; 2002 Aug; 62(15):4199-201. PubMed ID: 12154018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-78773: a selective, potent 5-lipoxygenase inhibitor.
    Bell RL; Brooks DW; Young PR; Lanni C; Stewart AO; Bouska J; Malo PE; Carter GW
    J Lipid Mediat; 1993; 6(1-3):259-64. PubMed ID: 8395248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Aug; 69(4):663-7. PubMed ID: 6159940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.
    Scannell RT; Arrington MP; Bayless L; Cai X; Eckman JB; Eckert M; Ene DG; Ellis JL; Hussoin S; Latham GM; Lewis TA; Libertine L; Nicolas J; Selig WM; Schwartz CE; Wels BF; Wypij DM; Young MA; Zou D
    Inflamm Res; 2004 Mar; 53 Suppl 1():S33-4. PubMed ID: 15054606
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis.
    Bell RL; Harris RR; Bouska JB; Hulkower KI; Moore J; Bhatia P; Malo PE; Kalosa T; Brooks CD; Carter GW
    Adv Exp Med Biol; 1997; 433():91-4. PubMed ID: 9561111
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma.
    Fukushima C; Shimoda T; Matsuse H; Matsuo N; Takao A; Obase Y; Kohno S; Asai S
    Ann Allergy Asthma Immunol; 1998 Mar; 80(3):245-50. PubMed ID: 9532973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition by azatadine of the immunological release of leukotrienes and histamine from human lung fragments.
    Daniels C; Temple DM
    Eur J Pharmacol; 1986 Apr; 123(3):463-5. PubMed ID: 2424773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
    Jonsson EW; Dahlén SE
    J Pharmacol Exp Ther; 1994 Nov; 271(2):615-23. PubMed ID: 7965776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H1 antagonists and histamine release from human lung in vitro [proceedings].
    Church MK; Gradidge CF
    Br J Pharmacol; 1979 May; 66(1):68P. PubMed ID: 88242
    [No Abstract]   [Full Text] [Related]  

  • 19. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J
    J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from monkey lung fragments].
    Takahashi K; Shono T
    Arerugi; 1986 Sep; 35(9):975-81. PubMed ID: 2432857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.